Cargando…
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
BACKGROUND: Quiescent tumor cells pose a major clinical challenge due to their ability to resist conventional chemotherapies and to drive tumor recurrence. Understanding the molecular mechanisms that promote quiescence of tumor cells could help identify therapies to eliminate these cells. Significan...
Autores principales: | Metz, Ethan P., Wuebben, Erin L., Wilder, Phillip J., Cox, Jesse L., Datta, Kaustubh, Coulter, Donald, Rizzino, Angie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528478/ https://www.ncbi.nlm.nih.gov/pubmed/32998722 http://dx.doi.org/10.1186/s12885-020-07370-7 |
Ejemplares similares
-
The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells
por: Cox, Jesse L., et al.
Publicado: (2013) -
Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells
por: Metz, Ethan P., et al.
Publicado: (2022) -
The dark side of SOX2: cancer - a comprehensive overview
por: Wuebben, Erin L., et al.
Publicado: (2017) -
SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
por: Wuebben, Erin L., et al.
Publicado: (2016) -
Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells
por: Cox, Jesse L., et al.
Publicado: (2012)